CIK: 1243514 - Address: C/O Viking Therapeutics, Inc., 9920 Pacific Heights Blvd, Suite 350, San Diego, CA 92121
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/25/24 19:27
10/25/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSingleton J MatthewCADM.d724.4801610D
10/25/24 19:27
10/25/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSingleton J MatthewCADS.d-1,27279.500-16-6310D
9/20/24 21:21
9/20/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSingleton J MatthewCADM.d121.1901010D
9/20/24 21:21
9/20/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSingleton J MatthewCADS.d-71669.500-10-5210D
8/22/24 19:23
8/21/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSingleton J MatthewCADM.d71.190615010D
8/22/24 19:23
8/21/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSingleton J MatthewCADS.d-39769.720-6-3810D
8/19/24 20:11
8/19/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSingleton J MatthewCADM.d533.3301610D
8/19/24 20:11
8/19/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSingleton J MatthewCADS.d-99562.220-16-6310D
8/14/24 20:03
8/14/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSingleton J MatthewCADM.d1668.0002110D
8/14/24 20:03
8/14/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSingleton J MatthewCADS.d-1,19657.530-21-6910D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact